Clinical application of terazosin combined with Qianlielongbitong in the treatment of chronic non-bacterial prostatitis

VernacularTitle:特拉唑嗪联合前列癃闭通胶囊治疗慢性前列腺炎临床研究
Author: Jihai CHEN ; Nong GU ; Guojing ZHANG ; Fei XIE ; Jiafa LI ; Qiusheng YUAN
Publication Type:Journal Article
Keywords: Prostatitis; Terazosin; Qianlielongbitong
From: Chinese Journal of Primary Medicine and Pharmacy 2012;19(11):1603-1604
CountryChina
Language:Chinese
Abstract: Objective To investigate the effect and mechanism of terazosin combined with Qianlielongbitong in the treatment of non-bacterial prostatitis.Methods One hundred and two patients with non-bacterial prostatitis were divided into two groups:one group was treated with terazosin 4 mg qn and Qianlielongbitong,while the other group was treated with terazosin and Levoofloxacin.We compared three indices of chronic prostatitis symptom index (NIH-CPSI),prostatic secretion examination(EPS) and urodynamic data in three different steps:before treatment,after 4-week treatment and after 8-week treatment.Results The NIH-CPSI of both groups was greatly improved after treatment( all P ＜0.01 ).Inside the treatment group,the NIH-C-PSI after 8-week treatment was better than that after 4- week treatment ( all P ＜ 0.01 ).However,in both groups,there was no significant difference between the index after 8-week treatment and the one after 4 week.EPS,AFR and MFR were greatly improved in both groups( all P ＜0.01 ).Conclusion Terazosin can relieve the clinical symptom,and improve the life quality.